Adam Koppel

Insider Reports History

Location
Boston, MA
Signature
/s /Kristian Humer, Attorney-in-Fact for Adam Koppel
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam Koppel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Solid Biosciences Inc. Director, 10%+ Owner Common Stock 4,034,582 $22,311,238 $5.53 11 Jan 2024 Indirect
Foghorn Therapeutics Inc. Director Stock Options (Right to buy) 16,000 $88,320 $5.52 26 Jun 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Common Stock 0 $0 $41.18 01 Aug 2024 Indirect
Aptinyx Inc. Director, 10%+ Owner Stock Option (Right to Buy) 40,000 26 May 2022 Direct
Solid Biosciences Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 9,650 06 Jun 2023 Direct
Cerevel Therapeutics Holdings, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 0 01 Aug 2024 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 28 Dec 2021 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 28 Dec 2021 Indirect
Dicerna Pharmaceuticals Inc Director Director Stock Option (Right to Buy) 0 28 Dec 2021 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 28 Dec 2021 Direct

Insider Reports Filed by Adam Koppel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FHTX Foghorn Therapeutics Inc. 29 Dec 2024 0 $0 4 Director 30 Dec 2024, 07:54
/report/000095017024090903-koppel-adam-2024-08-01 Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 4 $0 4 Director, 10%+ Owner 05 Aug 2024, 16:49
FHTX Foghorn Therapeutics Inc. 26 Jun 2024 1 +$88,320 4 Director 28 Jun 2024, 16:00
/report/000095017024070855-koppel-adam-2024-06-05 Cerevel Therapeutics Holdings, Inc. 05 Jun 2024 1 $0 4 Director, 10%+ Owner 07 Jun 2024, 17:12
SLDB Solid Biosciences Inc. 11 Jan 2024 1 +$5,000,005 4 Director, 10%+ Owner 12 Jan 2024, 16:56
/report/000089924323019971-koppel-adam-2023-10-16 Cerevel Therapeutics Holdings, Inc. 16 Oct 2023 1 +$124,999,986 4 Director, 10%+ Owner 18 Oct 2023, 16:30
FHTX Foghorn Therapeutics Inc. 21 Jun 2023 1 $0 4 Director 22 Jun 2023, 20:12
/report/000089924323015220-koppel-adam-2023-06-07 Cerevel Therapeutics Holdings, Inc. 07 Jun 2023 3 $0 4 Director, 10%+ Owner 09 Jun 2023, 17:07
SLDB Solid Biosciences Inc. 06 Jun 2023 1 $0 4 Director, 10%+ Owner 08 Jun 2023, 17:01
SLDB Solid Biosciences Inc. 13 Dec 2022 1 $0 4 Director, 10%+ Owner 15 Dec 2022, 17:19
SLDB Solid Biosciences Inc. 02 Dec 2022 1 $0 4 Director, 10%+ Owner 05 Dec 2022, 16:16
SLDB Solid Biosciences Inc. 02 Dec 2022 0 $0 3 Director, 10%+ Owner 05 Dec 2022, 15:58
FHTX Foghorn Therapeutics Inc. 21 Jun 2022 1 $0 4 Director 22 Jun 2022, 20:59
/report/000089924322022864-koppel-adam-2022-06-14 Cerevel Therapeutics Holdings, Inc. 14 Jun 2022 1 $0 4 Director, 10%+ Owner 16 Jun 2022, 17:10
/report/000089924322020206-koppel-adam-2022-05-26 Aptinyx Inc. 26 May 2022 1 $0 4 Director, 10%+ Owner 31 May 2022, 17:06
/report/000089924321050036-koppel-adam-2021-12-28 Dicerna Pharmaceuticals Inc 28 Dec 2021 9 -$117,946,552 4 Director 29 Dec 2021, 15:43
FHTX Foghorn Therapeutics Inc. 13 Jul 2021 1 $0 4 Director 14 Jul 2021, 16:53
SLDB Solid Biosciences Inc. 16 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:15
/report/000089924321023729-koppel-adam-2021-06-10 Cerevel Therapeutics Holdings, Inc. 10 Jun 2021 1 $0 4 Director, 10%+ Owner 14 Jun 2021, 20:25
/report/000089924321022369-koppel-adam-2021-06-03 Dicerna Pharmaceuticals Inc 03 Jun 2021 4 $0 4 Director 07 Jun 2021, 18:50
/report/000089924321021320-koppel-adam-2021-05-27 Aptinyx Inc. 27 May 2021 1 $0 4 Director, 10%+ Owner 01 Jun 2021, 16:30